Search results
South Korea report: domestic sales drop 11% in May
Just Auto via Yahoo Finance· 1 day agoExports plunged 64% to 4,777 vehicles in May from 13,376 units a year earlier and were down by 49% at 23,959 units YTD from 47,001 units. The company...
Marjorie Taylor Greene Just Loaded Up on Stocks: Here Are the 6 She Bought
Motley Fool via Yahoo Finance· 6 days agoIt's not clear how much Greene invested in each of the stocks, though each transaction was valued...
California State Teachers Retirement System Buys 7,779 Shares of Intuitive Surgical, Inc....
ETF DAILY NEWS· 2 days agoCalifornia State Teachers Retirement System lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 1.4% in the 4th quarter, according to the company in ...
California State Teachers Retirement System Acquires 24,768 Shares of Medtronic plc (NYSE:MDT)
ETF DAILY NEWS· 2 days agoCalifornia State Teachers Retirement System grew its position in Medtronic plc (NYSE:MDT – Free Report) by 1.2% during the fourth quarter, according to the company in its ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 2 days agoProgress in the LIBERATE trial was presented at the American Transplant Congress today London, UK– June 4, 2024 – Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical
How Can Cardiovascular Risk Be Reduced in Kidney Dialysis?
Medscape· 15 hours agoNew data on clazakizumab, a monoclonal antibody targeting interleukin-6 (IL-6), and home hemodialysis suggest the potential of two ways to reduce the high risk for cardiovascular events in people ...
Healing the brain: Biotech to test new therapy for stroke
Medical Xpress· 1 day agoA 3-year-old Sewickley, Pennsylvania, biotech firm is partnering with a Boston hospital to test a new drug combination, which has the promise of helping people debilitated by stroke. Neuro-Innovators ...
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell...
Morningstar· 6 days agoU.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma In the MCL cohort of TRANSCEND NHL < ...
CNS Pharmaceuticals Announces Reverse Stock Split
Digital Journal· 2 days agoThe par value of the common stock will remain unchanged at $0.001 per share after the reverse split, and the number of authorized shares of common stock will remain at 300 ...
High Confidence AD Drug Donanemab Will Get FDA Panel Nod
Medscape· 2 days agoThe Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug...
